ASX Announcement

US patent allowed for CHM 0201 (CORE-NK) technology

Published: 05/04/24, 08:50am (AEST)2 pages
Chimeric Therapeutics
CHM:ASXHealthcare

Recent CHM Announcements

Price Sensitive only